Canale Comm

25 email addresses found for canalecomm.com
{first.last}@canalecomm.com
25 email addresses
http://amplyx.com July 7, 2017
http://amplyx.com/amplyx-pharmaceuticals-announces-qualified-infectious-disease-product-designation-for-apx001-in-three-life-threatening-fungal-infections July 7, 2017
http://amplyx.com/amplyx-pharmaceuticals-appoints-ciara-kennedy-ph-d-as-president-and-chief-executive-officer July 7, 2017
http://amplyx.com/amplyx-pharmaceuticals-appoints-paul-c-grint-m-d-to-board-of-directors July 7, 2017
http://biocominstitute.org/about_us/news/ October 10, 2015
http://bio.org/media/press-release/san-diego-interim-mayor-todd-gloria-discuss-economic-development-initiatives-sup March 3, 2016
http://biospace.com/news/avalon-ventures-glaxosmithkline-launch-sitari/316677 May 5, 2017
http://biospace.com/news/bicom-and-baybio-bay-area-bioscience-association/338267 January 1, 2015
http://biospace.com/news_print.aspx April 4, 2015
http://biospace.com/news_story.aspx April 4, 2015
http://bioxcellence.com/press_archive/press/2012/21_february_2012xencor.html November 11, 2015
http://boehringer-ingelheim.com.mx/centro_de_prensa1/pressreleases/2012/14-02-201_boehringeringelheimyxencorinicianunacuerdodecolaboraci.html January 1, 2016
http://boehringer-ingelheim.com/news/news_releases/press_releases/2012/21_february_2012xencor.html March 3, 2016
http://califesciences.org/clsa-biocom-respond-to-rep-darrell-issa-on-patent-litigation-legislation-comments March 3, 2016
http://cert1.mail-west.com/anmc7rmgmyjtz/q321gmgtmyuzj/ptiqx/gmu0d1mb/21gmqvnq/su4vi1btcss3/bnza January 1, 2015
http://drugs.com/news/afraxis-grants-exclusive-global-license-genentech-42810.html May 5, 2015
http://effector.com/2016/03/18/effector-therapeutics-to-present-at-the-american-association-for-cancer-research-2016-annual-meeting April 4, 2016
http://effector.com/news April 4, 2016
http://life-sciences-uk.com/news/avalon-ventures-gsk-launch-glaxosmithkline-plc-lse-nyse-2001-106021.html May 5, 2017
http://prnewswire.com/news-releases/biocom-and-baybio-release-first-ever-california-life-science-industry-economic-impact-and-workforce-trends-reports-at-the-bio-international-convention-264603891.html January 1, 2015
http://prnewswire.com/news-releases/california-life-sciences-association--biocom-respond-to-rep-darrell-issa-on-patent-litigation-legislation-comments-300146575.html August 8, 2017
http://prnewswire.com/news-releases/effector-therapeutics-initiates-dosing-in-phase-12-clinical-trial-of-eft508-in-solid-tumors-300200141.html July 7, 2017
http://prnewswire.com/news-releases/lumena-pharmaceuticals-receives-positive-opinion-for-orphan-drug-designation-in-the-european-union-for-lum001-in-four-rare-liver-diseases-232328501.html April 4, 2015
http://rivervest.com/feed April 4, 2015
http://rivervest.com/feed/atom March 3, 2016
http://stockguru.com/2016/10/04/otonomy-successfully-completes-phase-2-clinical-trial-of-otiprio-in-pediatric-patients-with-acute-otitis-media-with-tympanostomy-tubes July 7, 2017
http://stockguru.com/2016/10/07/otonomy-holds-investor-and-analyst-day-and-provides-corporate-update July 7, 2017
http://tm-partners.com/news/061611.html March 3, 2016
http://tocagen.com/press/tocagen-doses-first-patient-intravenously-in-clinical-trial-of-selective-cancer-therapy-toca-511-toca-fc April 4, 2015
http://xencor.com/2011/10/xencor-initiates-phase-1-study-of-xmab%C2%AE5871-therapeutic-antibody-for-the-treatment-of-autoimmune-diseases-dual-targeted-antibody-aims-to-treat-lupus-and-rheumatoid-arthritis-by-suppressing-autoi April 4, 2015
http://acastipharma.ca/contactez April 4, 2017
http://acastipharma.com/contact December 12, 2016
http://bluerocktx.com/news December 12, 2017
http://cnbc.com/2017/10/18/globe-newswire-niri-san-diego-announces-its-board-of-directors-for-the-2017-2018-program-season.html January 1, 2018
http://communiquedepresse.ca/acasti-pharma-et-cordenpharma-annoncent-une-production-a-grande-echelle-de-capremd-avec-le-nouveau-procede-de-fabrication-en-continu September 9, 2017
http://communiquedepresse.ca/acasti-pharma-prsentera-prochainement-deux-confrences-internationales-de-lindustrie September 9, 2017
http://communiquedepresse.ca/nasdaq/page/3 September 9, 2017
http://communiquedepresse.ca/nasdaq/page/4 September 9, 2017
http://communiquedepresse.ca/page/218 January 1, 2018
http://cordenpharma.com/press-release/acasti-pharma-cordenpharma-announce-large-scale-production-of-capre-with-new-continuous-manufacturing-process September 9, 2017
http://crwepressrelease.com/press-release/10693/acasti-pharma-reports-positive-capre-omega-3-bridging-study-data November 11, 2016
http://crweworld.com/article/press-releases/38660/acasti-pharma-reports-positive-capre-omega-3-bridging-study-data March 3, 2017
http://einpresswire.com/article/361747694/acasti-pharma-reports-third-quarter-2017-financial-results August 8, 2017
http://marketwatch.com/story/acasti-pharma-announces-closings-of-concurrent-public-offering-of-units-and-private-placement-of-convertible-debentures-and-warrants-2017-02-23-181603531 September 9, 2017
http://marketwired.com/press-release/acasti-pharma-annonce-le-prix-de-son-placement-public-dunites-tsx-croissance-acst-2195213.htm July 7, 2017
http://marketwired.com/press-release/acasti-pharma-annonce-ses-resultats-pour-le-troisieme-trimestre-de-lexercice-2017-2188263.htm March 3, 2017
http://marketwired.com/press-release/acasti-pharma-announces-pricing-for-its-public-offering-of-units-tsx-venture-acst-2195212.htm July 7, 2017
http://marketwired.com/press-release/acasti-pharma-grants-incentive-stock-and-options-tsx-venture-acst-2198501.htm August 8, 2017
http://marketwired.com/press-release/acasti-pharma-reports-third-quarter-2017-financial-results-tsx-venture-acst-2188241.htm May 5, 2017
http://nirisd.org November 11, 2016
http://pharmablogue.com/acasti-pharma-annonce-un-placement-prive-propose-de-debentures-convertibles-et-un-placement-propose-dunites-modifie March 3, 2017
http://tdc.uhnresearch.ca/category/latest-news August 8, 2017
http://thewealthiestinvestor.com/acasti-pharma-grants-stock-options-marketwatch September 9, 2017
http://traderpower.com/category/news November 11, 2017
http://universalcells.com/bluerock-therapeutics-and-universal-cells-enter-collaboration-and-license-agreement-to-generate-gene-edited-ips-cell-lines November 11, 2017
http://wn.com/canal_1 September 9, 2017
http://azbio.org/calimmune-expands-board-of-directors-names-r-scott-greer-as-chairman January 1, 2016
http://frazierhealthcare.com/news/tobira-therapeutics-completes-patient-recruitment-for-centaur-phase-2b-study-of-cenicriviroc-in-nash-with-liver-fibrosis January 1, 2016
http://j-alz.com/content/neurocentria%e2%80%99s-lead-compound-mmfs-01-improves-brain-age-9-years-human-study-older-adults November 11, 2015
http://j-alz.com/print/59893 November 11, 2015
http://kuraoncology.com/faheem-hasnain-joins-kura-oncology-board-of-directors March 3, 2016
http://kuraoncology.com/first-patient-dosed-in-phase-2-study-of-tipifarnib-in-advanced-cancers-with-hras-mutations March 3, 2016
http://kuraoncology.com/investor/frequent-answers-to-questions March 3, 2016
http://kuraoncology.com/kuraoncology-announces-license-agreement-with-janssen-biotech-for-development-and-commercialization-of-tipifarnib-closes-58-4-million-private-placement-and-completes-merger March 3, 2016
http://kuraoncology.com/kura-oncology-to-present-at-the-jefferies-2015-global-healthcare-conference/ September 9, 2015
http://leadingbiosciences.com/news July 7, 2016
http://marketwired.com/press-release/trillium-therapeutics-to-present-new-data-from-tti-621-phase-1-trial-2196068.htm July 7, 2017
http://mtspartners.com/news/regado-biosciences-and-tobira-therapeutics-announce-merger-agreement-to-create-leading-nash-company March 3, 2016
http://mtspartners.com/news/regado-biosciences-and-tobira-therapeutics-announce-merger-agreement-to-create-leading-nash-company/ September 9, 2015
http://neurocentria.com/news March 3, 2016
http://nielsenbio.com/about-us/corporate-news September 9, 2015
http://nielsenbio.com/about-us/corporate-news/media-contact September 9, 2015
http://nielsenbio.com/about-us/corporate-news/nielsen-biosciences-spherusol-provides-physicians-with-new-test-for-valley-fever-april-9-2015 January 1, 2016
http://nielsenbio.com/about-us/corporate-news/nielsen-biosciences-spherusol-valley-fever-test-incorporated-into-medicare-payment-for-coccidioidomycosis-skin-test August 8, 2016
http://nielsenbio.com/contact-us September 9, 2015
http://nielsenbiosciences.com/about-us/corporate-news February 2, 2016
http://nielsenbiosciences.com/about-us/corporate-news/media-contact February 2, 2016
http://nielsenbiosciences.com/about-us/corporate-news/nielsen-biosciences-spherusol-provides-physicians-with-new-test-for-valley-fever-april-9-2015 February 2, 2016
http://nielsenbiosciences.com/about-us/corporate-news/nielsen-biosciences-spherusol-valley-fever-test-incorporated-into-medicare-payment-for-coccidioidomycosis-skin-test February 2, 2016
http://nielsenbiosciences.com/contact-us February 2, 2016
http://patarapharma.com September 9, 2016
http://pm360online.com/2016/09/page/20 September 9, 2016
http://rxtimes.com/calimmune-ceo-louis-breton-named-to-pharmavoice-100-for-2016-2 August 8, 2016
http://trilliumtherapeutics.com/contact/contactinformation/default.aspx June 6, 2016
http://trilliumtherapeutics.com/investors/news/press-release-details/2016/trillium-announces-voting-results-from-the-annual-and-special-meeting-of-shareholders/default.aspx June 6, 2016
http://trilliumtherapeutics.com/investors/news/press-release-details/2016/trillium-reports-first-quarter-2016-financial-results/default.aspx June 6, 2016
http://aravis.asia/news/2012/03/anaphore-announces-acquisition-of-ruiyi-in-shanghai-china-for-gpcr-biologics-drug-discovery-platform July 7, 2017
http://aravis.ch/news/2012/03/anaphore-announces-acquisition-of-ruiyi-in-shanghai-china-for-gpcr-biologics-drug-discovery-platform March 3, 2016
http://aravis.dk/news/2012/03/anaphore-announces-acquisition-of-ruiyi-in-shanghai-china-for-gpcr-biologics-drug-discovery-platform November 11, 2017
http://aravis.info/news/2012/03/anaphore-announces-acquisition-of-ruiyi-in-shanghai-china-for-gpcr-biologics-drug-discovery-platform July 7, 2017
http://aravispartners.ch/news/2012/03/anaphore-announces-acquisition-of-ruiyi-in-shanghai-china-for-gpcr-biologics-drug-discovery-platform July 7, 2017
http://biocomconcierge.org/professional/mediapr/canalecomm March 3, 2017
http://biocomhr.org/sd/speaker/jamie-tereschuck-2-2-2 January 1, 2017
http://bio-medicine.org/biology-news-1/biocom-announces-2013-san-diego-mayoral-primary-endorsement-31914-1 October 10, 2016
http://biospace.com/article/releases/biocom-announces-2013-san-diego-mayoral-primary-endorsement- November 11, 2017
http://biospace.com/news/biocom-announces-2013-san-diego-mayoral-primary/311447 January 1, 2015
http://canalecomm.com/about April 4, 2016
http://canalecomm.com/dvteam/carin-canale-theakston April 4, 2016
http://newswire.ca/news-releases/advancing-neuroscience-mri-interventions-imris-and-tocagen-combine-technologies-to-precisely-deliver-potential-cancer-fighting-drug-to-brain-tumors-512491371.html December 12, 2017
http://prnewswire.com/news-releases/biocom-announces-2013-san-diego-mayoral-primary-endorsement-227093531.html August 8, 2017
http://sdvg.org/board/ September 9, 2015
http://tocagen.com/press/musella-foundation-awards/ September 9, 2015
http://allegrodx.com October 10, 2015
http://aravis.asia/news/2012/10/anaphore-announces-name-change-to-ruiyi-and-new-additions-to-shanghai-management-team October 10, 2017
http://aravis.asia/news/2012/10/ruiyi-formerly-anaphore-and-argen-x-announce-exclusive-worldwide-license-agreement-for-argx-109-a-novel-anti-il-6-antibody July 7, 2017
http://aravis.ch/news/2012/10/anaphore-announces-name-change-to-ruiyi-and-new-additions-to-shanghai-management-team March 3, 2016
http://aravis.ch/news/2012/10/ruiyi-formerly-anaphore-and-argen-x-announce-exclusive-worldwide-license-agreement-for-argx-109-a-novel-anti-il-6-antibody March 3, 2016
http://aravis.info/news/2012/10/anaphore-announces-name-change-to-ruiyi-and-new-additions-to-shanghai-management-team October 10, 2017
http://aravis.info/news/2012/10/ruiyi-formerly-anaphore-and-argen-x-announce-exclusive-worldwide-license-agreement-for-argx-109-a-novel-anti-il-6-antibody October 10, 2017
http://aravispartners.ch/news/2012/10/anaphore-announces-name-change-to-ruiyi-and-new-additions-to-shanghai-management-team October 10, 2017
http://aravispartners.ch/news/2012/10/ruiyi-formerly-anaphore-and-argen-x-announce-exclusive-worldwide-license-agreement-for-argx-109-a-novel-anti-il-6-antibody October 10, 2017
http://benzinga.com/pressreleases/15/11/g5964582/raptor-pharmaceutical-corp-reports-third-quarter-2015-financial-results July 7, 2017
http://beta.san.org/news/article-detail/artmid/952/articleid/29/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs September 9, 2017
http://beta.san.org/news/article-detail/artmid/952/articleid/29/biocom-partners-with-san-diego-international-airport-arts-program-to-showcase-scientific-breakthroughs September 9, 2017
http://biospace.com/news/bicom-ceo-joe-panetta-appointed-to-california/320917 July 7, 2015
http://biospace.com/news/genomedx-biosciences-announces-data-on-genomic/329886 May 5, 2016
http://biospace.com/news_story.aspx April 4, 2015
http://fiercedevops.com/node/23911/print September 9, 2015
http://fiercedevops.com/press-releases/veracyte-announces-national-network-agreement-aetna September 9, 2015
http://firstwordpharma.com/node/1353335 January 1, 2016
http://prnewswire.com/news-releases/biocom-ceo-joe-panetta-appointed-to-california-institute-for-regenerative-medicines-independent-citizens-oversight-committee-by-governor-jerry-brown-239990941.html May 5, 2015
http://prnewswire.com/news-releases/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs-261857011.html January 1, 2015
http://prnewswire.com/news-releases/genomedx-biosciences-announces-data-on-genomic-tests-for-prostate-and-bladder-cancer-to-be-presented-at-eau-annual-meeting-254880531.html January 1, 2015
http://raptorpharma.com/about-raptor/contact March 3, 2016
http://raptorpharma.com/about-raptor/contact-us September 9, 2015
http://sancraa.org/airport-art/news/article-detail/artmid/1003/articleid/29/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs June 6, 2016
http://sancraa.org/news/article-detail/artmid/952/articleid/29/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs June 6, 2016
http://san.org/airport-art/news/article-detail/artmid/1003/articleid/29/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs January 1, 2016
http://san.org/news/article-detail/artmid/952/articleid/29/biocom-partners-with-san-diego-international-airport-art-program-to-showcase-scientific-breakthroughs October 10, 2015
http://san.org/news/article-detail/artmid/952/articleid/29/biocom-partners-with-san-diego-international-airport-arts-program-to-showcase-scientific-breakthroughs September 9, 2017
http://stockguru.com/2015/11/05/raptor-pharmaceutical-corp-reports-third-quarter-2015-financial-results-and-provides-corporate-update September 9, 2017
http://thestreet.com/story/12858165/1/raptor-pharmaceutical-to-present-at-upcoming-investor-conference-in-september.html January 1, 2015
15 more results for canalecomm.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month.

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about canalecomm.com

Industry: Internet and Telecom

Language of the website: English

Main technologies used: